M. P. Whyte, W. H. Reinus, and S. Mumm, High-bone mass disease and LRP5, N Engl J Med, vol.350, pp.2096-2105, 2004.

M. P. Whyte, Primer on the metabolic bone diseases and disorders of mineral metabolism, pp.769-85, 2013.

C. L. Gregson, S. A. Hardcastle, and C. Cooper, Friend or foe: high bone mineral density on routine bone density scanning, a review of causes and management, Rheumatology (Oxford), vol.52, pp.968-85, 2013.

M. P. Whyte, Misinterpretation of osteodensitometry with high bone density: BMD Z > or = + 2.5 is not 'normal, J Clin Densitom, vol.8, p.1, 2005.

C. L. Gregson, S. A. Steel, . O'rourke, and . Kp, Sink or swim': an evaluation of the clinical characteristics of individuals with high bone mass, Osteoporos Int, vol.23, pp.643-54, 2012.

I. R. Reid, M. C. Evans, and R. Ames, The influence of osteophytes and aortic calcification on spinal mineral density in postmenopausal women, J Clin Endocrinol Metab, vol.72, pp.1372-1376, 1991.

L. A. Westerveld, J. J. Verlaan, and M. G. Lam, The influence of diffuse idiopathic skeletal

N. Ustün, I. Ustün, and T. Ozgür, Diffuse osteosclerosis in a patient with prostate cancer

, Osteoporos Int, vol.25, pp.1181-1186, 2014.

L. Michou and J. P. Brown, Genetics of bone diseases: Paget's disease, fibrous dysplasia, osteopetrosis, and osteogenesis imperfecta, Joint Bone Spine, vol.78, pp.252-260, 2011.

J. G. Kennedy, J. R. Donahue, and H. Aydin, Metastatic breast carcinoma to bone disguised by osteopoikilosis, Skeletal Radiol, vol.32, pp.240-243, 2003.

S. Joshi, T. Hlaing, and G. M. Whitford, Skeletal fluorosis due to excessive tea and toothpaste consumption, Osteoporos Int, vol.22, pp.2557-60, 2011.

A. Wittenberg, The rugger jersey spine sign, Radiology, vol.230, pp.491-493, 2004.

V. Jevtic, Imaging of renal osteodystrophy, Eur J Radiol, vol.46, pp.85-95, 2003.

B. C. Silva, M. R. Rubin, and N. E. Cusano, Bone imaging in hypoparathyroidism

, Osteoporos Int, vol.28, pp.463-471, 2017.

T. Diamond, A. Smith, and R. Schnier, Syndrome of myelofibrosis and osteosclerosis: a series of case reports and review of the literature, Bone, vol.30, pp.498-501, 2002.

S. Barete, N. Assous, and C. De-gennes, Systemic mastocytosis and bone involvement in a cohort of 75 patients, Ann Rheum Dis, vol.69, pp.1838-1879, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00528144

F. Cagavi, M. Kalayci, and I. O. Tekin, Primary spinal extranodal Hodgkin's disease at two levels, Clin Neurol Neurosurg, vol.108, pp.168-73, 2006.

U. Yaga, P. Panta, and . Osteopetrosis, N Engl J Med, vol.376, p.34, 2017.

O. D. Benichou, B. Benichou, and H. Copin, Further evidence for genetic heterogeneity within type II autosomal dominant osteopetrosis, J Bone Miner Res, vol.15, pp.1900-1904, 2000.

A. Smahi, G. Courtois, and S. H. Rabia, The NF-kappaB signalling pathway in human diseases: from incontinentia pigmenti to ectodermal dysplasias and immune-deficiency syndromes, Hum Mol Genet, vol.11, pp.2371-2376, 2002.

C. M. Roberts, J. E. Angus, and I. H. Leach, A novel NEMO gene mutation causing osteopetrosis, lymphoedema, hypohidrotic ectodermal dysplasia and immunodeficiency (OLHED-ID), Eur J Pediatr, vol.169, pp.1403-1410, 2010.

Z. L. Zhang, J. W. He, and H. Zhang, Identification of the CLCN7 gene mutations in two Chinese families with autosomal dominant osteopetrosis (type II), J Bone Miner Metab, vol.27, pp.444-51, 2009.

E. Kida, S. Palminiello, and A. A. Golabek, Carbonic anhydrase II in the developing and adult human brain, J Neuropathol Exp Neurol, vol.65, pp.664-74, 2006.

G. N. Shah, G. Bonapace, and P. Y. Hu, Carbonic anhydrase II deficiency syndrome (osteopetrosis with renal tubular acidosis and brain calcification): novel mutations in CA2 identified by direct sequencing expand the opportunity for genotype-phenotype correlation, Hum Mutat, vol.24, p.272, 2004.

A. H. Van-lierop, N. M. Appelman-dijkstra, and S. E. Papapoulos, Sclerostin deficiency in humans, Bone, vol.96, pp.51-62, 2017.

. Van-hul, . Balemans, and . Van-hul, Van Buchem disease (hyperostosis corticalis generalisata) maps to chromosome 17q12-q21, Am J Hum Genet, vol.62, pp.391-399, 1998.

W. Balemans, N. Patel, and M. Ebeling, Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease, J Med Genet, vol.39, pp.91-98, 2002.

F. Cosman, D. B. Crittenden, and J. D. Adachi,

, Postmenopausal Women with Osteoporosis, N Engl J Med, vol.375, pp.1532-1543, 2016.

A. H. Van-lierop, N. A. Hamdy, and M. E. Van-egmond, Van Buchem disease: clinical, biochemical, and densitometric features of patients and disease carriers, J. Bone Miner. Res, vol.28, pp.848-854, 2013.

L. M. Boyden, J. Mao, and J. Belsky, High bone density due to a mutation in LDLreceptor-related protein 5, N Engl J Med, vol.346, pp.1513-1534, 2002.

L. Van-wesenbeeck, E. Cleiren, and J. Gram, Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density

, Am J Hum Genet, vol.72, pp.763-71, 2003.

M. S. Patel and G. Karsenty, Regulation of bone formation and vision by LRP5, N Engl J Med, vol.346, pp.1572-1576, 2002.

M. P. Whyte, W. H. Reinus, and S. Mumm, High-bone-mass disease and LRP5, N Engl J Med, vol.350, pp.2096-2105, 2004.

H. M. Worth and D. G. Wollin, Hyperostosis corticalis generalista congenita, J Canad Assoc Radiol, vol.17, pp.67-74, 1966.

N. Alonso, D. C. Soares, and E. Mccloskey, Atypical femoral fracture in osteoporosis pseudoglioma syndrome associated with two novel compound heterozygous mutations in LRP5, J Bone Miner Res, vol.30, pp.615-635, 2015.

O. Leupin, E. Piters, and C. Halleux, Bone overgrowth-associated mutations in the LRP4 gene impair sclerostin facilitator function, J Biol Chem, vol.286, pp.19489-500, 2011.

I. Fijalkowski, E. Geets, and E. Steenackers, A Novel Domain-Specific Mutation in a

, Sclerosteosis Patient Suggests a Role of LRP4 as an Anchor for Sclerostin in Human Bone, J Bone Miner Res, vol.31, pp.874-81, 2016.

B. D. Gelb, G. P. Shi, and H. A. Chapman, Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency, Science, vol.273, pp.1236-1244, 1996.

J. Freyschmidt, Melorheostosis: a review of 23 cases, Eur Radiol, vol.11, pp.474-483, 2001.

J. Hellemans, O. Preobrazhenska, and A. Willaert, Loss-of-function mutations in LEMD3 result in osteopoikilosis, Buschke-Ollendorff syndrome and melorheostosis, Nat Genet, vol.36, pp.1213-1221, 2004.

C. L. Gregson, L. Wheeler, and S. A. Hardcastle, Mutations in Known Monogenic High Bone Mass Loci Only Explain a Small Proportion of High Bone Mass Cases, J Bone Miner Res, vol.31, pp.640-649, 2016.

C. L. Gregson, A. Sayers, and V. Lazar, The high bone mass phenotype is characterised by a combined cortical and trabecular bone phenotype: findings from a pQCT case-control study, Bone, vol.52, pp.380-388, 2013.

S. A. Hardcastle, P. Dieppe, and C. L. Gregson, Osteoarthritis and bone mineral density: are strong bones bad for joints?, Bonekey Rep, vol.4, p.624, 2015.

D. Plessis and J. J. , Sclerosteosis: neurosurgical experience with 14 cases, Tableau 1 : principales causes des hyperdensités osseuses acquises et artéfactuelles Causes artéfactuelles, vol.78, pp.388-392, 1993.